Temozolomide and VNP40101M in Treating Patients With Relapsed or Refractory Leukemias

NCT00098436 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Leukemia

Interventions

DRUG: laromustine
DRUG: temozolomide

Sponsor

Vion Pharmaceuticals